INTRODUCTION
Studies of the catabolism of the triglyceride-rich lipoproteins of plasma, chylomicrons (2-4) and very low A preliminary report of this work has been published (1) . production of VLDL. Preliminary experiments showed that maximal incorporation of label into cholesteryl esters of serum VLDL occurred about 6 h after injection of [PH]-cholesterol into the tail vein of an unanesthetized rat. A short-lived peak of incorporation into VLDL-triglyceride appeared 30 min after injection of [14C]palmitate. Accordingly, these time intervals were used to obtain appropriately labeled VLDL. The rats were not fed after the injections. They were bled from the abdominal aorta under diethyl ether anesthesia and the blood was allowed to clot for 30 min at room temperature. Serum, obtained from blood centrifuged at 900 g for 15 min, was chilled and centrifuged at its own density for 16 h at 100,000 g at 10°C in the 40.3 rotor of a Beckman preparative ultracentrifuge (Beckman Instruments, Inc., Fullerton, Calif.). The supernatant d < 1.006 lipoproteins were recovered by tube slicing and used for injection into recipient rats on the same day. For determination of the chemical composition of VLDL, separate portions of the d < 1.006 lipoproteins were recentrifuged once under the same conditions.
Only about 30% of the labeled cholesterol in the VLDL obtained as described above was esterified. Initial experiments included, therefore, as did part of Goodman's work with chylomicrons (14) , a procedure for reducing radioactivity in free cholesterol. Blood obtained from male Sprague-Dawley rats weighing about 400 g was mixed with EDTA, 1 mg/ml, and centrifuged at 900 g for 15 min at 40C. The plasma and buffy coat were removed and the erythrocytes were washed three times with 4 vol of Tyrode's solution from which CaCl2 had been omitted. After storage overnight in the wash solution and a final centrifugation, the erythrocytes (10 ml/mg VLDL protein) were mixed with the VLDL and modified Tyrode's solution to give a hematocrit of about 357. The mixture was incubated at 370C for 6 h with gentle shaking. After sedimentation of the cells by centrifugation, VLDL were reisolated by ultracentrifugation, as described. Lipids of erythrocytes were extracted with 30 parts of chloroform: methanol, 2: 1 vol/vol (15) . This procedure increased the ratio of esterified [3H]-cholesterol to free [3H] cholesterol by approximately 10-fold without appreciably affecting the content of esterified [3H]-cholesterol. As described in the following section, it also modified the rate of VLDL removal from plasma. Accordingly, subsequent experiments did not include this step.
Injection of VLDL into recipicent animbals. The rats had been maintained on standard Purina rat chow and weighed about 250 g. Plasma triglyceride concentration was 0.80 (SD 0.32) mg/ml. Esterified cholesterol concentrations in d < 1.006 and d 1.019-1.063 lipoproteins were 0.020 (SD 0.006) and 0.063 ( SD 0.018) mg/ml plasma, respectively. At about noon the animals were placed in a restraining cage, and 0.5-1.0 ml of VLDL, containing less than 0.7 mg triglyceride, was injected into a tail vein. At selected intervals, they were anesthetized with diethyl ether and bled from the abdominal aorta. The blood was mixed with EDTA, 1 mg/ml, chilled in ice, and centrifuged at 900 g for 20 min at 4°C. Except as noted below, 0.1 volume of 0.02 NI 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) (Sigma Chemical Co., St. Louis, Mo.) was added to each sample of plasma to inhibit lecithin: cholesterol acyltransferase (LCAT) (16 (19) and the lipids were separated by silicic acid column chromatography (20) . Extracts of tissues were filtered through Whatman filter paper No. 1 and a portion of the filtrate containing less than 50 mg lipid was evaporated to dryness under nitrogen, redissolved in 50 ml chloroform: methanol, 25: 1 vol/vol, and treated with 4 g freshly activated silicic acid (Mallinckrodt Chemical Works, St.
Louis, Mo.) to absorb the bulk (about 99%/c) of the phospholipids. Lipid classes were then separated as described above. Cholesterol (21), triglycerides (22) , and phospholipids (23) were measured in appropriate fractions. 'H was assayed by liquid scintillation spectrometry after the lipids were dissolved in toluene containing 2,5-diphenyloxazole and 1,4-bis [2-(5-phenyloxazolyl) ]-benzene. Correction for quenching, when necessary, was performed with an internal standard.
Argentation thin layer chromatography of cholesteryl esters (24) was performed with Adsorbosil containing 25% AgNO: (Applied Sciences Labs, Inc., State College, Pa.). Methyl esters of fatty acids of cholesteryl esters were separated by gas-liquid chromatography on a w-in X 11-ft column of 12% ethylene glycol succinate on Chromosorb W (Applied Sciences Labs, Inc.) at 1850C (25) . Distribution in weight per cent was determined by multiplying peak height by retention time.
Column chromatography of intact lipoproteins on 2%/c Agarose gel was performed as described by Sata, Estrich, Wood, and Kinsell (26) . Apolipoproteins, extracted by tetramethylurea, were separated by polyacrylamide gel electrophoresis (27) , and the activator property of VLDLproteins for lipoprotein lipase was measured as described by Bier and Havel (28) . Standard methods of statistical analysis were employed (29 The nonpolar "core" constituents, triglycerides and cholesteryl esters, constituted about 78% of the particle -volume (30) . This indicates an average particle diameter of about 550 A (30) . VLDL from the fructosefed animals contained significantly more cholesteryl esters. No consistent differences between the polyacrylamide gel patterns of the tetramethylurea-soluble apolipoprotein components of VLDL from rats on the two diets were observed. VLDL from fructose-fed rats were separated by gel filtration through a 2% Agarose column (Table II) . About 10% of the cholesteryl esters were recovered in the void volume, in particles about 750 A in diameter (fraction 1). The remainder were eluted in a broad second peak with an average particle diameter of about 550 cpm h FIGURE A (fractions [2] [3] [4] . The specific activity of esterified cholesterol was somewhat higher in fractions of the second peak than in the material eluted in the void volume.
The specific activity of different classes of cholesteryl esters separated by argentation thin layer chromatography was: saturated, 81%; monounsaturated, 95%; diunsaturated, 109%; and tetraunsaturated, 138% of the value for unfractionated esters. (See Tables VII and   VIII) .
Effect of incubation of VLDL with erythrocytes.
Equilibration of free cholesterol between VLDL and erythrocytes was nearly complete after 6 h ( Fig. 1 ).
The ratio of 3H in esterified cholesterol to that in free cholesterol increased from 0.41 to 4.51. Incubation with erythrocytes also modified the composition of VLDL (Table III) . Content of free cholesterol increased significantly, indicating that net transfer of cholesterol from erythrocytes to VLDL also occurred. Content of phospholipids fell slightly. Polyacrylamide gel patterns of the tetramethylurea-soluble apolipoproteins were sim- When VLDL that had been incubated with erythrocytes were injected into recipient animals, the esterified [3H]cholesterol was removed rapidly from the plasma and taken up in the liver, as in the experiments with unincubated VLDL to be described below. However, this process took place more rapidly after incubation (Fig. 2) . In another experiment, incubated and unincubated VLDL, labeled in both the cholesterol and triglyceride fatty acid moieties, were injected. 5 After 30 and 60 min, respectively, 58% and 80% of the esters had been hydrolyzed.
These results are similar to those obtained in studies of chylomicron cholesteryl esters, which indicated uptake of intact esters by hepatocytes and subsequent hydrolysis in the region of the plasma membrane (14, 31, 32) . However, both the rate of removal of the esters from the plasma and the rate of their hydrolysis in the liver were somewhat higher in our VLDL studies. This is unlikely to reflect physiological differences in metabolism, since large triglyceride-rich particles are more rapidly metabolized than small ones under the same experimental conditions (31) . Rather, it probably reflects differences in the amount of lipoprotein injected (32) . Per rat we injected less than 0.7 mg VLDL-tri- glyceride, which corresponds to less than 10% of the triglycerides circulating in the plasma of these animals.
In the cited studies with chylomicrons, from 20 to 50 times as much lipoprotein-lipid was injected. When smaller amounts of chylomicrons are inj ected into unanesthetized rats, the half-life of component triglycerides is about 3 min and, as with our VLDL, a minor fraction appears in hepatic triglycerides (33) . Of the esterified [3H]cholesterol removed from plasma VLDL after 60 min, only 3.4% was found in LDL (d 1.019-1.063) . The distribution of label in the various esters of LDL was identical to that of the VLDL esters injected and the esters taken up by the liver. In functionally hepatectomized rats, "remnant" particles depleted of triglycerides but retaining component cholesteryl esters are formed from VLDL (34, 35) as well as from chylomicrons (3, 34) . In intact rats, most of these particles, while still in the very low density (< 1.006) or intermediate density (1.006-1.019) range, evidently leave the circulation in the liver with their full complement of cholesteryl esters, but only a minority of the triglycerides originally present. A small fraction, however, which recent studies have shown to be larger in the guinea pig,4 loses enough triglyceride to be isolated, with its complement of cholesterol esters, in the d 1.019-1.063 range as LDL. Whether the cholesteryl esters that appear in LDL are initially taken up by the liver and subsequently released into the blood is uncertain. The fraction of VLDL that completes the conversion to LDL may be much larger in man. In this context it may be noted that only a small fraction of apolipoprotein B is transferred to LDL during catabolism of VLDL in the rat (9, 10, 36) , in contrast to the human, where as much as 10-25% (6, 8) Mean and SD. (40) or transfer of small amounts of labeled esters from HDL determined the differences in the rates of appearance of label in d < 1.019 lipoproteins of plasma, rather than different turnover rates once the cholesteryl esters had been incorporated into these lipoproteins.
The labeled VLDL we employed for injection into recipient rats were presumably mainly of hepatic origin. When particulate cholesterol is injected intravenously into rats, the major part is quickly taken up by the liver's Kupffer cells, from which it is subsequently released to a pool of exchangeable free cholesterol (41) . As such, it is available for esterification in the liver, the major site of VLDL synthesis. The intestine plays a smaller but significant role in production of VLDL (42) , but intestinal VLDL-cholesterol in the rat is mainly derived from the intestinal lumen (43) . Hepatic synthesis of cholesteryl esters that are then returned to the liver and hydrolyzed constitutes an apparently The incubation procedure, however, modified the VLDL so that, when injected into recipient rats, they were removed from the blood much more rapidly by the liver. Since these VLDL had acquived free cholesterol and lost phospholipids, both surface components of the lipoprotein (30), it is possible that their "recognition" by the liver was altered, with premature removal from the circulation as a result. Free cholesterol of unincubated VLDL was also rapidly and extensively taken up by the liver, although more was recovered in d > 1.006 lipoproteins, presumably because of molecular exchange. The extensive hepatic uptake of both surface and core components of presumed VLDL remnants suggests that the particle may be taken up intact before its components are further metabolized.
